LETTER TO EDITOR |
[Download PDF] |
|
| Year : 2010 | Volume
: 42
| Issue : 3 | Page : 197--198 |
Authors' reply
Richa Vaishya1, J Singh2, Harbans Lal1,
1 Department of Biochemistry, Pt. BD Sharma Postgraduate Institute of Medical Science, Rohtak, Haryana, India
2 Department of Pharmacology, Pt. BD Sharma Postgraduate Institute of Medical Science, Rohtak, Haryana, India
Correspondence Address:
Richa Vaishya
Department of Biochemistry, Pt. BD Sharma Postgraduate Institute of Medical Science, Rohtak, Haryana
India
How to cite this article:
Vaishya R, Singh J, Lal H. Authors' reply.Indian J Pharmacol 2010;42:197-198
|
How to cite this URL:
Vaishya R, Singh J, Lal H. Authors' reply. Indian J Pharmacol [serial online] 2010 [cited 2023 Jun 5 ];42:197-198
Available from: https://www.ijp-online.com/text.asp?2010/42/3/197/66850 |
Full Text
Sir,
We thank Dr. Mahajan for his comments [1] on our paper. [2] Our reply to the queries are as follows:
The study was planned to focus the beneficial effects of irbesartan in comparison to insulin and thus the relevance of the study remains clear.Suggestion at 2 is well-taken for future studies.We regret the typing error; please read group III for insulin and group IV for irbesartan.It is a printing error. The original [Table 1] and [Table 2] submitted to the journal office are reproduced here.
References
| 1 | Mahajan. Irbesartan in experimental diabetic nephropathy. Indian J Pharmacol 2010;42:197. |
| 2 | Vaishya R, Singh J, Lal H. Biochemical effects of irbesartan in experimental diabetic nephropathy. Indian J Pharmacol 2009;41:252-4. |
|
